Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | ACLY | P53396 | 2/20 | 0.50 |
| ▸ | ACACA | Q13085 | 2/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma Oryzanol SCHEMBL23105398 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL21235210 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL12152368 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL29354302 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| Gamma Oryzanol SCHEMBL718726 | 1.00 | MEN1 (0.60) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL10049046 | 0.94 | MEN1 (0.53) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL31149054 | 0.94 | ACLY (0.52) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL10017450 | 0.90 | MEN1 (0.51) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL12152371 | 0.90 | MEN1 (0.63) | MEN1KMT2AACLYACACARELA | |
| SCHEMBL29524845 | 0.90 | MEN1 (0.63) | MEN1KMT2AACLYACACARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023175391-A1 | EMULSIONS AS OXIDATION PROTECTANTS FOR CONVENTIONAL FRYING OILS IN FOOD APPLICATIONS | ALIANZA TEAM INTERNATIONAL S.A. (CO) | 2023-09-21 | — | — | WO | claimed |
| CN-115537062-A | 3D printing ink material, preparation method thereof and bracket-free invisible appliance with shape memory function | 烟台先进材料与绿色制造山东省实验室 | 2022-12-30 | — | — | CN | claimed |
| US-12414977-B2 | Method of administering seaberry and saw palmetto extracts to inhibit 5α-reductase activity | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20250268972-A1 | 5a-REDUCTASE INHIBITOR | ORYZA OIL & FAT CHEMICAL CO., LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| WO-2025048546-A1 | COMPOSITION FOR IMPROVING SKIN CONDITION | 주식회사 엘지생활건강 | 2025-03-06 | — | — | WO | disclosed |
| EP-4510992-A2 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | Bobo Labs Inc. (US) | 2025-02-26 | — | — | EP | disclosed |
| CN-119343126-A | Skin barrier protection delivery system and method thereof | 宝宝实验室公司 | 2025-01-21 | — | — | CN | disclosed |
| US-20250017830-A1 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | BOBO LABS INC. (US) | 2025-01-16 | — | — | US | disclosed |
| US-12121603-B1 | Skin barrier protective delivery systems | BOBO LABS INC. (US) | 2024-10-22 | — | — | US | disclosed |
| WO-2024205344-A1 | COSMETIC COMPOSITION FOR AMELIORATING SKIN AGING | 주식회사 엘지생활건강 | 2024-10-03 | — | — | WO | disclosed |
| US-20240325265-A1 | SKIN BARRIER PROTECTIVE DELIVERY SYSTEMS AND METHODS THEREOF | BOBO LABS INC. | 2024-10-03 | — | — | US | disclosed |
| WO-2022170114-A1 | SKINCARE COMPOSITIONS AND METHODS OF USE THEREOF | MODERN MEADOW, INC. (US) | 2022-08-11 | — | — | WO | disclosed |
| CN-114656590-A | Degradable thermosetting 3D printing mold and preparation method thereof | 中国科学院福建物质结构研究所 | 2022-06-24 | — | — | CN | disclosed |
| CN-114591601-A | Preparation method of multifunctional 4D printing material | 中国科学院福建物质结构研究所 | 2022-06-07 | — | — | CN | disclosed |
| WO-2022092284-A1 | COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER | 日産化学株式会社 | 2022-05-05 | — | — | WO | disclosed |
| EP-3558236-B1 | LIQUID PERSONAL CLEANSING COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2022-04-13 | — | — | EP | disclosed |
| CN-110381916-B | Liquid personal cleansing compositions | 联合利华知识产权控股有限公司 | 2022-04-08 | — | — | CN | disclosed |
| US-20220062121-A1 | MICROEMULSION COMPOSITION, CURED MATERIAL THEREOF, AND COSMETIC CONTAINING THE CURED MATERIAL | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-03-03 | — | — | US | disclosed |
| CN-112111038-B | Water-soluble photosensitive resin and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2022-02-18 | — | — | CN | disclosed |
| EP-3222269-B1 | HAIR PAPILLA CELL ACTIVATOR | EZAKI GLICO CO (JP) | 2022-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220062121-A1 | MICROEMULSION COMPOSITION, CURED MATERIAL THEREOF, AND COSMETIC CONTAINING THE CURED MATERIAL | MGLL, LIPA, MAN2B1 | MEN1 320/4885KMT2A 1856/4885ACLY 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.